Scarica l'app Stockscreener
3.7829
4.72%
0.1829
Precedente Chiudi:
$3.60
Aprire:
$3.62
Volume 24 ore:
430.88K
Relative Volume:
0.54
Capitalizzazione di mercato:
$249.90M
Reddito:
$69.23M
Utile/perdita netta:
$-33.10M
Rapporto P/E:
-3.2058
EPS:
-1.18
Flusso di cassa netto:
$-39.26M
1 W Prestazione:
+6.50%
1M Prestazione:
+8.02%
6M Prestazione:
+53.25%
1 anno Prestazione:
+88.50%
Intervallo 1D:
$3.56
$3.7887
Intervallo di 1 settimana:
$3.42
$4.00
Portata 52W:
$0.52
$5.92
Neuronetics Inc Stock (STIM) Company Profile
Nome
Neuronetics Inc
Settore
Industria
Telefono
877-600-7555
Indirizzo
3222 PHOENIXVILLE PIKE, MALVERN, PA
Confronta STIM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
3.7799 | 231.40M | 69.23M | -33.10M | -39.26M | -1.18 |
|
ABT
Abbott Laboratories
|
121.58 | 231.78B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.14 | 152.32B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
388.83 | 149.83B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.83 | 114.03B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.00 | 45.28B | 5.54B | 4.18B | 623.10M | 7.00 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-13 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-10-13 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | Iniziato | BTIG Research | Buy |
| 2018-07-24 | Iniziato | Canaccord Genuity | Buy |
Mostra tutto
Neuronetics Inc Borsa (STIM) Ultime notizie
Neuronetics Appoints New CFO as Company Targets Growth and Profitability Milestones - MSN
Neuronetics names Steven Pfanstiel as CFO - Medical Buyer
What makes Neuronetics Inc. stock price move sharplyTrade With Low Risk Exposure - Newser
Why Neuronetics Inc. stock attracts strong analyst attentionFree Stock Market Forecasting Tools - Newser
Neuronetics, Inc. Announces Chief Financial Officer Changes - MarketScreener
Neuronetics Appoints Steven Pfanstiel As CFO; Reaffirms Q2, FY25 Guidance - Nasdaq
Neuronetics appoints new chief financial officer - MarketScreener
Neuronetics Appoints New CFO Amid Strategic Expansion - TipRanks
Neuronetics Appoints Steven Pfanstiel as CFO - MarketScreener
Neuronetics Appoints Steven Pfanstiel as New Chief Financial Officer, Reiterates Financial Guidance for 2025 - Nasdaq
Neuromodulation Devices Market is projected to reach USD 190.14 - openPR.com
Transcranial Magnetic Stimulator Market Set to Witness - openPR.com
Neuronetics Showcases NeuroStar TMS Data at Clinical TMS Meeting - Yahoo Finance
Neuronetics, Inc.(NasdaqGM: STIM) added to Russell Small Cap Completeness Index - MarketScreener
Neuronetics, Inc.(NasdaqGM: STIM) added to Russell 2500 Index - MarketScreener
Neuronetics reports inducement grant - Medical Buyer
Neuronetics to Join Russell 3000 and Russell 2000 Indexes, Boosting Institutional Visibility - MSN
Insider Sellers Might Regret Selling Neuronetics Shares at a Lower Price Than Current Market Value - simplywall.st
Neuronetics to join Russell 3000 and Russell 2000 indexes - MSN
Neuronetics Announces Clinical Presence At The 2025 Clinical TMS Society Annual Meeting And Progress In Greenbrook's Personalized Care Trial Program - MarketScreener
Neuronetics (STIM) Showcases Innovations in Mental Health Care | - GuruFocus
Neuronetics Announces Clinical Presence at the 2025 Clinical TMS - GuruFocus
Neuronetics (STIM) Showcases Innovations in Mental Health Care | STIM Stock News - GuruFocus
Neuronetics to Present New Research on TMS Therapy at 13th Annual Clinical TMS Society Meeting - Nasdaq
Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program - The Manila Times
NeuroStar's Groundbreaking Study Shows How Its Depression Treatment Compares to Rival Brainsway: Key Findings - Stock Titan
Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes - The Manila Times
Neuronetics set to join Russell indexes in June By Investing.com - Investing.com South Africa
Neuronetics set to join Russell indexes in June - Investing.com India
Neuronetics (STIM) to Join Russell 3000 and Russell 2000 Indexes - GuruFocus
Neuronetics Set To Join Russell 2000® And Russell 3000® Indexes - marketscreener.com
Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes | STIM Stock News - GuruFocus
Neuronetics, Inc. to Join Russell 3000® and Russell 2000® Indexes Effective June 30, 2025 - Nasdaq
Major Milestone: Neuronetics Joins Russell 2000 and 3000 Indexes, Tapping Into $10.6T Benchmark Market - Stock Titan
Transcranial Magnetic Stimulator Market Future Business - openPR.com
Neuronetics reports annual meeting results By Investing.com - Investing.com Canada
Neuronetics reports annual meeting results - Investing.com Australia
Neuronetics Holds Annual Meeting, Elects Directors - TipRanks
Transcranial Magnetic Stimulators (TMS) Market to Set - openPR.com
Neuronetics' SWOT analysis: stock outlook brightens post-merger By Investing.com - Investing.com UK
Neuronetics’ SWOT analysis: stock outlook brightens post-merger By Investing.com - Investing.com Canada
Neuronetics’ SWOT analysis: stock outlook brightens post-merger - Investing.com
Neuronetics Posts Strong Revenue Growth in Q1 2025 - MSN
Insider Sell: Stephen Furlong Sells 200,000 Shares of Neuronetics Inc (STIM) - GuruFocus
Why We Think Neuronetics, Inc.'s (NASDAQ:STIM) CEO Compensation Is Not Excessive At All - simplywall.st
Neuronetics Inc Azioni (STIM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.59%
0.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):